Preventing the development of severe COVID-19 by modifying immunothrombosis
journal contribution
posted on 2021-01-01, 00:00 authored by G Morris, Chiara BortolasciChiara Bortolasci, B K Puri, Lisa OliveLisa Olive, Wolf MarxWolf Marx, Adrienne O'NeilAdrienne O'Neil, Eugene AthanEugene Athan, A Carvalho, M Maes, Ken WalderKen Walder, Michael BerkMichael BerkPreventing the development of severe COVID-19 by modifying immunothrombosis
History
Journal
Life sciencesVolume
264Article number
118617Pagination
1 - 15Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
Link to full text
ISSN
0024-3205eISSN
1879-0631Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Read the peer-reviewed publication
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalPharmacology & PharmacyResearch & Experimental MedicineCOVID-19SARS-CoV-2Respiratory infectionTreatmentNF-KAPPA-BACETYL-L-CYSTEINEOBSTRUCTIVE PULMONARY-DISEASERESPIRATORY-DISTRESS-SYNDROMEACUTE LUNG INJURYASPIRIN-TRIGGERED LIPOXINSVITAMIN-C PHARMACOKINETICSBRONCHIAL EPITHELIAL-CELLSOXIDATIVE STRESS MARKERSZINC TRANSPORTER ZIP14